Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Diabetes & Metabolism|April 25, 2025
Musculoskeletal disorders in type 1 diabetes: Clinical phenotyping and associations with quality of life and glucose control - The French SFDT1 cohort studyNoémie Topalian, Sylvie Picard, Jean-Pierre Riveline, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 23, 2021
Impact of a Remote Monitoring Programme Including Lifestyle Education Software in Type 2 Diabetes: Results of the Educ@dom Randomised Multicentre StudyMarie-Christine Turnin, Pierre Gourdy, Jacques Martini, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 7, 2021
Ten-year outcomes of islet transplantation in patients with type 1 diabetes: Data from the Swiss-French GRAGIL networkSandrine Lablanche, Sophie Borot, Anne Wojtusciszyn, et al.
The Lancet. Diabetes & Endocrinology|February 26, 2026
Tubeless automated insulin delivery versus multiple daily injections in children and adults with type 1 diabetes with elevated HbA<sub>1c</sub> (RADIANT): a multicentre, international, parallel-group, open-label, randomised, controlled trialEmma G Wilmot, Jacques Beltrand, Bruno Guerci, et al.
Diabetes, Obesity & Metabolism|November 25, 2025
A nationwide 12-month observatory of automated insulin delivery shows improved glucose control, sustained adoption, and reduced acute severe eventsJean-Pierre Riveline, Jean-Baptiste Julla, Elisabeth Bonnemaison, et al.
Diabetes Technology & Therapeutics|July 10, 2026
Sustained Follow-up of Automated Insulin Delivery in a Real-World Setting: Results at 2 Years of the French Nationwide Observatory OB2FJean-Baptiste Julla, Chloé Amouyal, Sandrine Lablanche, et al.
The Lancet. Digital Health|December 16, 2020
Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trialPierre-Yves Benhamou, Sylvia Franc, Yves Reznik, et al.
The Lancet. Diabetes & Endocrinology|September 9, 2024
Islet-after-kidney transplantation versus kidney alone in kidney transplant recipients with type 1 diabetes (KAIAK): a population-based target trial emulation in FranceMehdi Maanaoui, Rémi Lenain, Yohann Foucher, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 8, 2022
Cost-Effectiveness Evaluation of a Remote Monitoring Programme Including Lifestyle Education Software in Type 2 Diabetes: Results of the Educ@dom StudyMichael Mounié, Nadège Costa, Pierre Gourdy, et al.
The Lancet. Diabetes & Endocrinology|May 20, 2018
Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trialSandrine Lablanche, Marie-Christine Vantyghem, Laurence Kessler, et al.
Pageof 7